Follow
Konstantinos Vougas
Konstantinos Vougas
Research Scientist, Biomedical Research Foundation of the Academy of Athens
Verified email at bioacademy.gr - Homepage
Title
Cited by
Cited by
Year
Cellular senescence: defining a path forward
V Gorgoulis, PD Adams, A Alimonti, DC Bennett, O Bischof, C Bishop, ...
Cell 179 (4), 813-827, 2019
19692019
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing
P Galanos, K Vougas, D Walter, A Polyzos, A Maya-Mendoza, ...
Nature cell biology 18 (7), 777-789, 2016
2862016
A deep learning framework for predicting response to therapy in cancer
T Sakellaropoulos, K Vougas, S Narang, F Koinis, A Kotsinas, A Polyzos, ...
Cell reports 29 (11), 3367-3373. e4, 2019
1802019
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis
L Kolilekas, E Manali, KA Vlami, P Lyberopoulos, C Triantafillidou, ...
Journal of Clinical Sleep Medicine 9 (6), 593-601, 2013
1572013
The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where
IS Pateras, S Havaki, X Nikitopoulou, K Vougas, PA Townsend, ...
Pharmacology & therapeutics 154, 36-56, 2015
1462015
Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of …
E Gkogkou, G Barnasas, K Vougas, IP Trougakos
Redox biology 36, 101615, 2020
1452020
Systemic mechanisms and effects of ionizing radiation: A new⿿ old⿿ paradigm of how the bystanders and distant can become the players
Z Nikitaki, IV Mavragani, DA Laskaratou, V Gika, VP Moskvin, ...
Seminars in cancer biology 37, 77-95, 2016
1312016
Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
G Velimezi, M Liontos, K Vougas, T Roumeliotis, J Bartkova, M Sideridou, ...
Nature cell biology 15 (8), 967-977, 2013
1302013
The proteome profile of the human osteosarcoma U2OS cell line
KN Niforou, AK Anagnostopoulos, K Vougas, C Kittas, VG Gorgoulis, ...
Cancer genomics & proteomics 5 (1), 63-77, 2008
1292008
Brain proteome response following whole body exposure of mice to mobile phone or wireless DECT base radiation
AF Fragopoulou, A Samara, MH Antonelou, A Xanthopoulou, ...
Electromagnetic Biology and Medicine 31 (4), 250-274, 2012
1112012
Comparative analysis of label-free and 8-Plex iTRAQ approach for quantitative tissue proteomic analysis
A Latosinska, K Vougas, M Makridakis, J Klein, W Mullen, M Abbas, ...
PloS one 10 (9), e0137048, 2015
1092015
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining
K Vougas, T Sakellaropoulos, A Kotsinas, GRP Foukas, A Ntargaras, ...
Pharmacology & therapeutics 203, 107395, 2019
1062019
Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment
C Diamanti, E Manali, M Ginieri-Coccossis, K Vougas, K Cholidou, ...
Sleep and breathing 17, 1159-1168, 2013
992013
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
A Pavlopoulou, Y Oktay, K Vougas, M Louka, CE Vorgias, AG Georgakilas
Cancer letters 380 (2), 485-493, 2016
872016
Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma
A Kolialexi, GT Tsangaris, N Papantoniou, AK Anagnostopoulos, ...
Prenatal diagnosis 28 (8), 691-698, 2008
842008
Characterization of the human urine proteome by preparative electrophoresis in combination with 2‐DE
PG Zerefos, K Vougas, P Dimitraki, S Kossida, A Petrolekas, ...
Proteomics 6 (15), 4346-4355, 2006
732006
Marked defects in the expression and glycosylation of α2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and …
PM Karamessinis, A Malamitsi-Puchner, T Boutsikou, M Makridakis, ...
Molecular & Cellular Proteomics 7 (3), 591-599, 2008
692008
Protein biomarkers distinguish between high-and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
M Braoudaki, GI Lambrou, K Vougas, K Karamolegou, GT Tsangaris, ...
Journal of hematology & oncology 6, 1-20, 2013
602013
Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas
M Liontos, K Niforou, G Velimezi, K Vougas, K Evangelou, ...
The American journal of pathology 175 (1), 376-391, 2009
582009
Proteomics reveal rat hippocampal lateral asymmetry
A Samara, K Vougas, A Papadopoulou, E Anastasiadou, N Baloyanni, ...
Hippocampus 21 (1), 108-119, 2011
552011
The system can't perform the operation now. Try again later.
Articles 1–20